Month: October 2021

They remain susceptible to the virus for longer after the first vaccination, but achieve a mostly normal response after the second, a study says. View original article Contributor: Apoorva Mandavilli

The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations. View original article Contributor: Stephanie Nolen

Online fame can be taxing. For one new show, that’s a clever excuse to pay even more attention to a famous family. View original article Contributor: Amanda Hess

COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11. In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the … Read more

When Americans divide themselves into camps, they stick to them fiercely: Democrats versus Republicans, pro-life versus pro-choice, gun rights versus gun control. Add to that, as has become apparent over the course of the past year, those who are pro- versus anti-coronavirus vaccines. As with so many other polarizing issues, your position on getting or … Read more

Most guidelines and data on breast cancer have come from studies of white women of European descent. “I don’t experience the screening recommendations in the same way that white women do,” says Yvette Gullatt, chief diversity officer for the University of California system. “I experience breast cancer in Black women as highly aggressive and lethal. … Read more

Covid-19 was “the eighth-highest killer of kids in this age group over the past year,” said a C.D.C. official in favor of broader authorization. View original article Contributor: Sharon LaFraniere and Noah Weiland